Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.

Cancer - 15 May 2026

Grewal Udhayvir S, Patel Rishi R, Loeffler Bradley T, Rathjens Sydney, Abdilleh Kawther, Zelada-Arenas Fatima, Hornstein Nicholas J, Brown Timothy J, Concors Seth J, Fei Naomi H, Sharif Saima, Chandrasekharan Chandrikha

Abstract excerpt

BACKGROUND: Approximately 10%-15% of patients with pancreatic ductal adenocarcinoma (PDAC) harbor pathogenic germline genetic alterations with direct therapeutic and hereditary cancer implications, leading to guideline recommendations for universal germline genetic testing regardless of family history. METHODS: The authors conducted a cross-sectional electronic survey in collaboration with the Pancreatic Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Pancreatic Ductal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Genetic Counseling

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Pancreatic Neoplasms

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 42118569
DOI: 10.1002/cncr.70446
PMCID: PMC13166122

Genes

ATM
BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.PMID 42118569Read ↗

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.Semantic proximity Read ↗

Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.Semantic proximity Read ↗

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.Semantic proximity Read ↗

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.Semantic proximity Read ↗

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.Semantic proximity Read ↗

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.Semantic proximity Read ↗

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.Semantic proximity Read ↗

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic AdenocarcinomaSemantic proximity Read ↗

Expanding access to genetic testing for pancreatic cancer.Semantic proximity Read ↗

Evaluating Implementation of NCCN Guideline-Directed Genetic Screening Recommendations for Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain.Semantic proximity Read ↗

Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.